Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Challenges to initiate and complete a 4-month rifapentine-moxifloxacin TB treatment regimen.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: June 28, 2025
Acquired rifamycin resistance among patients with tuberculosis and HIV in New York City, 2001-2023.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: April 01, 2024
Rifampin Mono-Resistant Tuberculosis in New York City, 2010-2021: A Retrospective Case Series.
Journal: Open forum infectious diseases
Published: September 14, 2023
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 07, 2023
Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022.
Journal: PLOS global public health
Published: November 18, 2022
Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York.
Journal: Journal of clinical microbiology
Published: July 20, 2020
Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 30, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026